18.6% Below Target

AbbVie Inc. (ABBV) has a consensus 12-month price target of $256.92, implying 18.6% upside from $216.63. The 41 analysts covering ABBV see moderate appreciation potential.

ABBV has a consensus rating of "Buy" based on 41 Wall Street analysts. The rating breakdown is predominantly bullish, with 28 Buy/Strong Buy ratings. The consensus 12-month price target of $256.92 implies 18.6% upside from current levels.

With a forward P/E of 15.2068x, ABBV trades at a relatively low valuation. The consensus target of $256.92 implies 18.6% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $298 for ABBV, while the most conservative target is $223. The consensus of $256.92 represents the median expectation. Our quantitative valuation model projects a bull case target of $528 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

ABBV is heavily covered by Wall Street, with 41 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 28 have Buy ratings, 12 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month ABBV stock forecast based on 41 Wall Street analysts shows a consensus price target of $256.92, with estimates ranging from $223 (bear case) to $298 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $401, with bear/bull scenarios of $252/$528.

Our quantitative valuation model calculates ABBV's fair value at $401 (base case), with a bear case of $252 and bull case of $528. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.

ABBV trades at a forward P/E ratio of 15.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 91.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are optimistic on ABBV, with a "Buy" consensus rating and $256.92 price target (18.6% upside). 28 of 41 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

ABBV analyst price targets range from $223 to $298, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $256.92 consensus represents the middle ground. Our model's $252-$528 range provides an independent fundamental perspective.